Table 3.

Comparison of Demographics and Clinical characteristics between eyes that developed MvD and eyes that did not develop MvD during the follow-up

Variables	No MvD (21 eyes of 18 patients)	MvD during follow-up (17 eyes of 16 patients)	P value
Baseline Age (yrs)	70.2 (64.8, 75.6)	71.7 (66.2, 77.1)	0.701
Gender (Female/ Male)	10/8	8/8	0.746
Race (African American/ Non-African American)	7/11	6/10	0.934
Self-reported hypertension, n (%)	11 (61.1%)	9 (56.3%)	0.774
Self-reported diabetes, n (%)	1 (5.6%)	4 (25.0%)	0.110
Axial length (mm)	23.9 (23.4, 24.4)	23.9 (23.3, 24.5)	0.972
CCT (μm)	522.4 (498.9, 545.9)	545.6 (526.3, 565.0)	0.108
Baseline VF MD (dB)	−2.1 (−3.2, −1.1)	−3.1 (−4.4, −1.8)	0.207
Baseline RNFL Thickness (um)	88.6 (82.6, 94.7)	80.7 (74.6, 86.7)	0.064
Baseline IOP (mmHg)	15.0 (13.4, 16.7)	15.5 (13.5, 17.4)	0.742
Mean IOP during follow-up (mmHg)	14.9 (13.6, 16.3)	15.4 (12.7, 18.1)	0.773
IOP fluctuation (mmHg)	1.9 (1.5, 2.3)	3.5 (2.3, 4.7)	0.012
Peak IOP during follow-up (mmHg)	17.4 (15.9, 18.9)	20 (15.7, 24.3)	0.260
No. of glaucoma medications during the follow-up (n)	1.6 (1, 2.2)	2.5 (1.8, 3.3)	0.044
No. of eyes using glaucoma medication during the follow-up, n (%)	7.2 (6.9, 7.5)	7.1 (6.8, 7.4)	0.506
Glaucoma surgeries at baseline, n (%)	2 (10.0%)	5 (29.4%)	0.133
Cataract surgeries at baseline, n (%)	11 (52.4%)	10 (58.8%)	0.691
Scan Quality Score	7.2 (6.9, 7.5)	7.1 (6.8, 7.4)	0.506
Follow-up period (years)	3.7 (3.4, 4.0)	4.2 (3.8, 4.5)	0.021
No. of follow-up visits	5.0 (4.4, 5.5)	6.4 (5.6, 7.3)	0.002

CCT = central corneal thickness; IOP = intraocular pressure; MD = mean deviation; MvD = microvascular dropout; OCTA = optical coherence tomography angiography; VF = visual field.

^*Data is presented as mean (95% CI) unless otherwise indicated. Statistically significant P values are shown in bold.